PIM2 kinase has a pivotal role in plasmablast generation and plasma cell survival, opening up novel treatment options in myeloma.
Publié le 03/02/2022
- Blood
- pmid : 35108359
Haas M, Caron G, Chatonnet F, Manenti S, Alaterre E, Devin J, Delaloy C, Bertolin G, Viel R, Pignarre A, Llamas-Gutierrez F, Marchalot A, Decaux O, Tarte K, Delpy L, Moreaux J, Fest T
Devin J, Caneque T, Lin YL, Mondoulet L, Veyrune JL, Abouladze M, Garcia De Paco E, Karmous Gadacha O, Cartron G, Pasero P, Bret C, Rodriguez R, Moreaux J
en savoir plus
SETDB1/NSD-dependent H3K9me3/H3K36me3 dual heterochromatin maintains gene expression profiles by bookmarking poised enhancers.
Publié le 27/01/2022
- Mol Cell
- pmid : 35081363
Barral A, Pozo G, Ducrot L, Papadopoulos GL, Sauzet S, Oldfield AJ, Cavalli G, Déjardin J
Publié le 26/01/2022
- BioRxiv
Giuseppa Grasso, Charbel Akkawi, Celine Franckhauser, Rima Nait-Saidi, Maxime Bello, Jérôme Barbier, Rosemary Kiernan
en savoir plus
Publié le 25/01/2022
- Nucleic Acids Research
Lo Furno E., Busseau, I., Aze, A., Lorenzi, C., Saghira, C., Danzi, M., Zuchner, S., Maiorano, D.
en savoir plus
Four-pronged negative feedback of DSB machinery in meiotic DNA-break control in mice
Publié le 22/01/2022
- Nucleic Acid Research
Ihsan Dereli, Marcello Stanzione, Fabrizio Olmeda, Frantzeskos Papanikos, Marek Baumann, Sevgican Demir, Fabrizia Carofiglio, Julian Lange, Bernard de Massy, Willy M Baarends, James Turner, Steffen Rulands, Attila Tóth
Mechanisms of Polycomb group protein function in cancer.
Publié le 21/01/2022
- Cell Res
- pmid : 35046519
Parreno V, Martinez AM, Cavalli G
Activation of the ubiquitin-proteasome system contributes to oculopharyngeal muscular dystrophy through muscle atrophy.
Publié le 14/01/2022
- PLoS Genet
- pmid : 35025870
Ribot C, Soler C, Chartier A, Al Hayek S, Naït-Saîdi R, Barbezier N, Coux O, Simonelig M
Publié le 04/01/2022
- Cell Metabolism
Isabelle K.Vila, Hanane Chamma, Alizée Steer, Mathilde Saccas, Clara Taffoni, Evgenia Turtoi, Line S.Reinert, Saqib Hussain, Johanna Marines, Lei Jin, Xavier Bonnefont, Mathieu Hubert, Olivier Schwartz, Soren R.Paludan, Gaetan Van Simaeys, Gilles Doumont, Bijan Sobhian, Dimitrios Vlachakis, Andrei Turtoi, Nadine Laguette
en savoir plus
Angiogenic factors could help us to define patients obtaining complete response with undetectable minimal residual disease in untreated CLL patients treated by FCR: results from the CLL2010FMP, a FILO study.
Publié le 23/11/2021
- Leuk Lymphoma
- pmid : 34806520
Gagez AL, Paul F, Alaterre E, Gouilleux-Gruart V, Tuaillon E, Lepretre S, Ternant D, Letestu R, Moreaux J, Cartron G
Studying the DNA damage response in embryonic systems.
Publié le 16/11/2021
- Methods Enzymol
- pmid : 34776225
Lo Furno E, Recolin B, van der Laan S, Aze A, Maiorano D
Editorial: Nucleic Acid-Associated Inflammation.
Publié le 27/10/2021
- 34777401
Laguette N, Langevin C, Olagnier D, Torraca V, Vanpouille-Box C, Verrier ER.
RNA-Sequencing-Based Transcriptomic Score with Prognostic and Theranostic Values in Multiple Myeloma.
Publié le 24/10/2021
- J Pers Med
- pmid : 34683129
Alaterre E, Vikova V, Kassambara A, Bruyer A, Robert N, Requirand G, Bret C, Herbaux C, Vincent L, Cartron G, Elemento O, Moreaux J
A regulatory phosphorylation site on Mec1 controls chromatin occupancy of RNA polymerases during replication stress.
Publié le 28/09/2021
- EMBO J
- pmid : 34569643
Hurst V, Challa K, Jonas F, Forey R, Sack R, Seebacher J, Schmid CD, Barkai N, Shimada K, Gasser SM, Poli J
Targeting the methyltransferase SETD8 impairs tumor cell survival and overcomes drug resistance independently of p53 status in multiple myeloma.
Publié le 18/09/2021
- Clin Epigenetics
- pmid : 34530900
Herviou L, Ovejero S, Izard F, Karmous-Gadacha O, Gourzones C, Bellanger C, De Smedt E, Ma A, Vincent L, Cartron G, Jin J, De Bruyne E, Grimaud C, Julien E, Moreaux J
